EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Multi-omic profiling of simultaneous ductal carcinoma in situ and invasive breast cancer

Henry G Kaplan, Alexa K Dowdell, Anna B Berry, Racheli Ben Shimol, Fred L Robinson, Christopher A Carney, Brian D Piening

Breast Cancer Research and Treatment · 2024

DOI: 10.1007/s10549-024-07270-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Breast Cancer Research and Treatment, 2024. Verfasst von Henry G Kaplan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Swedish Cancer Institute, 1221 Madison St., Suite 920, Seattle, WA, 98104, USA. hank.kaplan@swedish.org. Hauptthemen laut MEDLINE: Carcinoma, Intraductal, Noninfiltrating, Breast Neoplasms, Mutation, DNA Copy Number Variations. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kaplan Cancer Research Fund, Providence Foundation of Oregon.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

The progression of ductal carcinoma in situ (DCIS) to invasive breast carcinoma (IBC) in humans is highly variable. To better understand the relationship between them, we performed a multi-omic characterization of co-occurring DCIS and IBC lesions in a cohort of individuals.

Methods

Formalin-fixed paraffin-embedded tissue samples from 50 patients with co-occurring DCIS and IBC lesions were subjected to DNA-seq and whole transcriptome RNA-seq. Paired DCIS and IBC multi-omics profiles were then interrogated for DNA mutations, gene expression profiles and pathway analysis.

Results

Most small variants and copy number variations were shared between co-occurring DCIS and IBC lesions, with IBC exhibiting on average a higher degree of additional mutations. However, 36% of co-occurring lesions shared no common mutations and 49% shared no common copy number variations. The most frequent genomic variants in both DCIS and IBC were PIK3CA, TP53, KMT2C, MAP3K1, GATA3 and SF3B1 , with KMT2C being more frequent in DCIS and TP53 and MAP3K1 more frequent in IBC, though the numbers are too small for definitive conclusions. The most frequent copy number variations were seen in MCL1, CKSB1 and ERBB2. ERBB2 changes were not seen in IBC unless present in the corresponding DCIS. Transcriptional profiles were highly distinct between DCIS and IBC, with DCIS exhibiting upregulation of immune-related signatures, while IBC showed significant overexpression in genes and pathways associated with cell division and proliferation. Interestingly, DCIS and IBC exhibited significant differential expression of different components of extracellular matrix (ECM) formation and regulation, with DCIS showing overexpression of ECM-membrane interaction components while IBC showed upregulation of genes associated with fibronectin and invadopodia.

Conclusion

While most co-occurring DCIS and IBC were mutationally similar and suggestive of a common clonal progenitor, transcriptionally the lesions are highly distinct, with IBC expressing key pathways that facilitate invasion and proliferation. These results are suggestive of additional levels of regulation, epigenetic or other, that facilitate the acquisition of invasive properties during tumor evolution.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Intraductal, NoninfiltratingBreast NeoplasmsMutationDNA Copy Number VariationsHumansFemaleGene Expression ProfilingCarcinoma, Ductal, BreastBiomarkers, TumorMiddle AgedNeoplasm InvasivenessGene Expression Regulation, NeoplasticTranscriptomeAgedAdultGenomicsMultiomics

Stichwörter der Autor:innen

Breast cancerDCISGenomicsRNA-seq

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Swedish Cancer Institute, 1221 Madison St., Suite 920, Seattle, WA, 98104, USA. hank.kaplan@swedish.org.
  • Earle A. Chiles Research Institute, Providence Health, Portland, OR, 97213, USA.
  • Swedish Cancer Institute, 1221 Madison St., Suite 920, Seattle, WA, 98104, USA.

Förderung

  • Kaplan Cancer Research Fund
  • Providence Foundation of Oregon

Zitieren

APA

Kaplan, H. G., Dowdell, A. K., Berry, A. B., Shimol, R. B., Robinson, F. L., Carney, C. A., & Piening, B. D. (2024). Multi-omic profiling of simultaneous ductal carcinoma in situ and invasive breast cancer. Breast Cancer Research and Treatment. https://doi.org/10.1007/s10549-024-07270-5

Vancouver

Kaplan HG, Dowdell AK, Berry AB, Shimol RB, Robinson FL, Carney CA, et al. Multi-omic profiling of simultaneous ductal carcinoma in situ and invasive breast cancer. Breast Cancer Research and Treatment. 2024. doi:10.1007/s10549-024-07270-5

BibTeX
@article{Kaplan2024,
  author = {Kaplan, Henry G and Dowdell, Alexa K and Berry, Anna B and Shimol, Racheli Ben and Robinson, Fred L and Carney, Christopher A and Piening, Brian D},
  title = {Multi-omic profiling of simultaneous ductal carcinoma in situ and invasive breast cancer},
  journal = {Breast Cancer Research and Treatment},
  year = {2024},
  doi = {10.1007/s10549-024-07270-5}
}
Kostenlos starten →